600380 健康元
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入11,898,829-5.95%16,646,35017,142,75315,903,68813,521,606
减:营业总成本9,121,682-8.71%13,123,51613,784,93813,169,41310,900,820
    其中:营业成本4,393,919-9.15%6,298,4666,252,2655,716,2944,874,187
               财务费用(105,969)-66.30%(404,841)(352,447)(92,895)(98,886)
               资产减值损失(113,694)4.84%(312,370)(142,628)(62,951)(80,787)
公允价值变动收益(5,736)-87.53%(25,420)(76,263)(23,506)10,218
投资收益51,650-11.81%79,47555,97371,881182,316
    其中:对联营企业和合营企业的投资收益34,370-40.61%72,79470,57810,28117,271
营业利润2,832,3835.06%3,506,5653,479,9362,983,0672,972,955
利润总额2,819,3155.25%3,465,5553,456,1052,952,3292,950,160
减:所得税费用385,618-11.11%614,536561,797339,480371,694
净利润2,433,6978.42%2,851,0192,894,3082,612,8492,578,466
减:非控股权益1,322,13613.86%1,408,2391,391,5311,284,3501,458,027
股东净利润1,111,5602.58%1,442,7801,502,7771,328,4991,120,440

市场价值指针
每股收益 (元) *0.5954.63%0.7580.7930.6860.575
每股派息 (元) *----0.1800.1800.1500.150
每股净资产 (元) *7.73010.84%7.3746.8026.1965.682
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容